229 related articles for article (PubMed ID: 9870253)
1. Epstein-Barr virus gene expression in post-transplant lymphoproliferative disorders.
Rowe M; Niedobitek G; Young LS
Springer Semin Immunopathol; 1998; 20(3-4):389-403. PubMed ID: 9870253
[No Abstract] [Full Text] [Related]
2. Epstein-Barr virus associated polymorphic lymphoproliferative disorders occurring in nontransplant settings.
Tao J; Wasik MA
Lab Invest; 2001 Apr; 81(4):429-37. PubMed ID: 11304562
[No Abstract] [Full Text] [Related]
3. The biology of Epstein-Barr virus in post-transplant lymphoproliferative disease.
Hsieh WS; Lemas MV; Ambinder RF
Transpl Infect Dis; 1999 Sep; 1(3):204-12. PubMed ID: 11428990
[TBL] [Abstract][Full Text] [Related]
4. Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders.
Haque T; Crawford DH
Springer Semin Immunopathol; 1998; 20(3-4):375-87. PubMed ID: 9870252
[No Abstract] [Full Text] [Related]
5. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
[TBL] [Abstract][Full Text] [Related]
6. Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.
Chen G; Chen L; Qin X; Huang Z; Xie X; Li G; Xu B
Int J Clin Exp Pathol; 2014; 7(10):7110-3. PubMed ID: 25400806
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for Epstein-Barr virus-associated malignancies.
Long HM; Parsonage G; Fox CP; Lee SP
Drug News Perspect; 2010 May; 23(4):221-8. PubMed ID: 20520851
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.
Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Terzi A; Karakuş S; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():183-7. PubMed ID: 25894151
[TBL] [Abstract][Full Text] [Related]
9. Detection of Epstein-Barr virus genomes in peripheral blood B cells from solid-organ transplant recipients by fluorescence in situ hybridization.
Rose C; Green M; Webber S; Kingsley L; Day R; Watkins S; Reyes J; Rowe D
J Clin Microbiol; 2002 Jul; 40(7):2533-44. PubMed ID: 12089275
[TBL] [Abstract][Full Text] [Related]
10. Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic post-transplant lymphoproliferative disorders and the signature of viral signaling.
Shaknovich R; Basso K; Bhagat G; Mansukhani M; Hatzivassiliou G; Murty VV; Buettner M; Niedobitek G; Alobeid B; Cattoretti G
Haematologica; 2006 Oct; 91(10):1313-20. PubMed ID: 17018379
[TBL] [Abstract][Full Text] [Related]
11. Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.
O'Reilly RJ; Small TN; Papadopoulos E; Lucas K; Lacerda J; Koulova L
Springer Semin Immunopathol; 1998; 20(3-4):455-91. PubMed ID: 9870257
[No Abstract] [Full Text] [Related]
12. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
Dolcetti R
Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
[TBL] [Abstract][Full Text] [Related]
13. Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.
Calabrese F; Loy M; Lunardi F; Marino D; Aversa SM; Rea F
Transpl Infect Dis; 2010 Aug; 12(4):342-6. PubMed ID: 20030794
[TBL] [Abstract][Full Text] [Related]
14. The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis.
Tanner JE; Alfieri C
Transpl Infect Dis; 2001 Jun; 3(2):60-9. PubMed ID: 11395971
[TBL] [Abstract][Full Text] [Related]
15. Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases.
Bernasconi M; Ueda S; Krukowski P; Bornhauser BC; Ladell K; Dorner M; Sigrist JA; Campidelli C; Aslandogmus R; Alessi D; Berger C; Pileri SA; Speck RF; Nadal D
Int J Cancer; 2013 Nov; 133(10):2341-50. PubMed ID: 23640782
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-related bilateral acute retinal necrosis in a patient with X-linked lymphoproliferative disorder.
Hershberger VS; Hutchins RK; Witte DP; Schneider S; Harris RE; McGonegle SJ
Arch Ophthalmol; 2003 Jul; 121(7):1047-9. PubMed ID: 12860814
[No Abstract] [Full Text] [Related]
17. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
Kalla M; Hammerschmidt W
Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease.
Rowe DT; Webber S; Schauer EM; Reyes J; Green M
Transpl Infect Dis; 2001 Jun; 3(2):79-87. PubMed ID: 11395973
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus (EBV)-encoded RNA: automated in-situ hybridization (ISH) compared with manual ISH and immunohistochemistry for detection of EBV in pediatric lymphoproliferative disorders.
Fanaian NK; Cohen C; Waldrop S; Wang J; Shehata BM
Pediatr Dev Pathol; 2009; 12(3):195-9. PubMed ID: 18442302
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomas. French Study Group of Pathology for HIV-associated Tumors.
Rea D; Delecluse HJ; Hamilton-Dutoit SJ; Marelle L; Joab I; Edelman L; Finet JF; Raphael M
Ann Oncol; 1994; 5 Suppl 1():113-6. PubMed ID: 8172807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
